Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -46,759 | -24,436 | -65,801 | -45,355 | -25,048 |
| Depreciation Amortization | 949 | 512 | 2,549 | 1,655 | 1,094 |
| Accounts receivable | 336 | -197 | -815 | N/A | N/A |
| Accounts payable and accrued liabilities | -1,352 | -338 | 1,065 | -390 | -55 |
| Other Working Capital | -5,476 | -4,409 | 1,833 | 3,346 | 2,851 |
| Other Operating Activity | 5,366 | 2,605 | 7,453 | 6,296 | 3,710 |
| Operating Cash Flow | $-46,936 | $-26,263 | $-53,716 | $-34,448 | $-17,448 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 26,546 | 25,796 | -22,046 | -31,709 | -37,579 |
| PPE Investments | -37 | -37 | -573 | -573 | -480 |
| Investing Cash Flow | $26,509 | $25,759 | $-22,619 | $-32,282 | $-38,059 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -347 | -172 | -510 | -341 | -233 |
| Common Stock Issued | 43,163 | 184 | 1,903 | 1,654 | 403 |
| Financing Cash Flow | $42,816 | $12 | $1,393 | $1,313 | $170 |
| Exchange Rate Effect | -95 | -23 | -15 | -18 | 11 |
| Beginning Cash Position | 16,980 | 16,980 | 91,937 | 91,937 | 91,937 |
| End Cash Position | 39,274 | 16,465 | 16,980 | 26,502 | 36,611 |
| Net Cash Flow | $22,294 | $-515 | $-74,957 | $-65,435 | $-55,326 |
| Free Cash Flow | |||||
| Operating Cash Flow | -46,936 | -26,263 | -53,716 | -34,448 | -17,448 |
| Capital Expenditure | -37 | -37 | -573 | -573 | -480 |
| Free Cash Flow | -46,973 | -26,300 | -54,289 | -35,021 | -17,928 |